Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 84

1.

Validation of extracellular ligand-receptor interactions by Flow-TriCEPS.

Lopez-Garcia LA, Demiray L, Ruch-Marder S, Hopp AK, Hottiger MO, Helbling PM, Pavlou MP.

BMC Res Notes. 2018 Dec 5;11(1):863. doi: 10.1186/s13104-018-3974-5.

2.

Ligand-based receptor identification on living cells and tissues using TRICEPS.

Frei AP, Moest H, Novy K, Wollscheid B.

Nat Protoc. 2013;8(7):1321-36. doi: 10.1038/nprot.2013.072. Epub 2013 Jun 13.

PMID:
23764939
3.

Direct identification of ligand-receptor interactions on living cells and tissues.

Frei AP, Jeon OY, Kilcher S, Moest H, Henning LM, Jost C, Plückthun A, Mercer J, Aebersold R, Carreira EM, Wollscheid B.

Nat Biotechnol. 2012 Oct;30(10):997-1001. doi: 10.1038/nbt.2354. Epub 2012 Sep 16.

PMID:
22983091
4.

Identification of Putative Receptors for the Novel Adipokine CTRP3 Using Ligand-Receptor Capture Technology.

Li Y, Ozment T, Wright GL, Peterson JM.

PLoS One. 2016 Oct 11;11(10):e0164593. doi: 10.1371/journal.pone.0164593. eCollection 2016.

5.

HATRIC-based identification of receptors for orphan ligands.

Sobotzki N, Schafroth MA, Rudnicka A, Koetemann A, Marty F, Goetze S, Yamauchi Y, Carreira EM, Wollscheid B.

Nat Commun. 2018 Apr 17;9(1):1519. doi: 10.1038/s41467-018-03936-z.

6.

Biotin-ligand complexes with streptavidin quantum dots for in vivo cell labeling of membrane receptors.

Lidke DS, Nagy P, Jovin TM, Arndt-Jovin DJ.

Methods Mol Biol. 2007;374:69-79.

PMID:
17237530
7.

Biotinylation and characterization of Cryptococcus neoformans cell surface proteins.

Foster AJ, Bird RA, Smith SN.

J Appl Microbiol. 2007 Aug;103(2):390-9.

8.

Intravenous siRNA of brain cancer with receptor targeting and avidin-biotin technology.

Xia CF, Zhang Y, Zhang Y, Boado RJ, Pardridge WM.

Pharm Res. 2007 Dec;24(12):2309-16. Epub 2007 Oct 11.

PMID:
17926121
10.

Protein L: a novel reagent for the detection of chimeric antigen receptor (CAR) expression by flow cytometry.

Zheng Z, Chinnasamy N, Morgan RA.

J Transl Med. 2012 Feb 13;10:29. doi: 10.1186/1479-5876-10-29.

11.

Time-domain microfluidic fluorescence lifetime flow cytometry for high-throughput Förster resonance energy transfer screening.

Nedbal J, Visitkul V, Ortiz-Zapater E, Weitsman G, Chana P, Matthews DR, Ng T, Ameer-Beg SM.

Cytometry A. 2015 Feb;87(2):104-18. doi: 10.1002/cyto.a.22616. Epub 2014 Dec 18.

12.

Estimation of affinities of ligands in mixtures via magnetic recovery of target-ligand complexes and chromatographic analyses: chemometrics and an experimental model.

Yang X, Xie Y, Pu J, Zhao H, Liao J, Yuan Y, Zhu S, Long G, Zhang C, Yuan H, Chen Y, Liao F.

BMC Biotechnol. 2011 May 5;11:44. doi: 10.1186/1472-6750-11-44.

13.

Rapid expression cloning of receptors using epitope-tagged ligands and high-speed cell sorting.

Robeva AS, Yan-Neale Y, Burfeind P, Bodian DL, Chirn GW, Kolbinger F, Labow M, Vallon RD.

Cytometry A. 2003 Feb;51(2):59-67.

15.

Tumor-specific delivery of therapeutic siRNAs by anti-EGFR immunonanoparticles.

Kim JS, Kim MW, Kang SJ, Jeong HY, Park SI, Lee YK, Kim HS, Kim KS, Park YS.

Int J Nanomedicine. 2018 Aug 27;13:4817-4830. doi: 10.2147/IJN.S161932. eCollection 2018.

16.

Amine Landscaping to Maximize Protein-Dye Fluorescence and Ultrastable Protein-Ligand Interaction.

Jacobsen MT, Fairhead M, Fogelstrand P, Howarth M.

Cell Chem Biol. 2017 Aug 17;24(8):1040-1047.e4. doi: 10.1016/j.chembiol.2017.06.015. Epub 2017 Jul 27.

17.

Insulin binding to human cultured lymphocytes measured by flow cytometry using three ligands.

Ziegler O, Cantin C, Germain L, Dupuis M, Sekaly RP, Drouin P, Chiasson JL.

Cytometry. 1994 Aug 1;16(4):339-45.

18.

Cell surface biotinylation of receptor tyrosine kinases to investigate intracellular trafficking.

Crupi MJ, Richardson DS, Mulligan LM.

Methods Mol Biol. 2015;1233:91-102. doi: 10.1007/978-1-4939-1789-1_9.

PMID:
25319892
19.

Antibody-mediated targeting of siRNA via the human insulin receptor using avidin-biotin technology.

Xia CF, Boado RJ, Pardridge WM.

Mol Pharm. 2009 May-Jun;6(3):747-51. doi: 10.1021/mp800194y.

20.

Supplemental Content

Support Center